EVIDA Trademark
Trademark Overview
On Monday, October 2, 2023, a trademark application was filed for EVIDA with the United States Patent and Trademark Office. The USPTO has given the EVIDA trademark a serial number of 98207152. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 19, 2024. This trademark is owned by Prometheus Laboratories, Inc.. The EVIDA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services, namely, medical diagnostic, evaluation and screening services; healthcare services, namely, disease management services; medical services, namely, therapeutic drug monitoring and precision-guided dosing services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of inflammatory and immune-mediated diseases, ulcerative colitis, Crohn's disease, rheumatological diseases, rheumatoid arthritis, psoriatic arthritis, system lupus erythematosus, dermatological diseases, psoriasis, hidradenitis suppurativa, neurological disease, Alzheimer's disease, and migraines; providing medical information relating to medical diagnostic testing; medical consultation; providing a website featuring health care information about services for the diagnosis, prevention, and treatment of inflammatory and immune-mediated diseases
Medical research laboratory services featuring testing for medical research purposes; medical research services; providing medical and scientific research information in the field of pharmaceuticals, pharmaceutical discovery and clinical trials to medical and research professionals; providing a website featuring medical research information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical discovery, pharmaceutical research and development, medical research laboratory testing, medical diagnostics, proteomics, metabolomics, glycomics, genomics and genetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals, proteomics, metabolomics, glycomics, genomics and genetics
General Information
| Serial Number | 98207152 |
| Word Mark | EVIDA |
| Filing Date | Monday, October 2, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 19, 2024 |
Trademark Statements
| Goods and Services | Medical services, namely, medical diagnostic, evaluation and screening services; healthcare services, namely, disease management services; medical services, namely, therapeutic drug monitoring and precision-guided dosing services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of inflammatory and immune-mediated diseases, ulcerative colitis, Crohn's disease, rheumatological diseases, rheumatoid arthritis, psoriatic arthritis, system lupus erythematosus, dermatological diseases, psoriasis, hidradenitis suppurativa, neurological disease, Alzheimer's disease, and migraines; providing medical information relating to medical diagnostic testing; medical consultation; providing a website featuring health care information about services for the diagnosis, prevention, and treatment of inflammatory and immune-mediated diseases |
| Goods and Services | Medical research laboratory services featuring testing for medical research purposes; medical research services; providing medical and scientific research information in the field of pharmaceuticals, pharmaceutical discovery and clinical trials to medical and research professionals; providing a website featuring medical research information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical discovery, pharmaceutical research and development, medical research laboratory testing, medical diagnostics, proteomics, metabolomics, glycomics, genomics and genetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals, proteomics, metabolomics, glycomics, genomics and genetics |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 12, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 12, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Prometheus Laboratories, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Prometheus Laboratories, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Thursday, October 5, 2023 | NEW APPLICATION ENTERED |
| Thursday, October 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 22, 2024 | ASSIGNED TO EXAMINER |
| Monday, August 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 19, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, August 19, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, August 19, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, August 19, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, August 19, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 19, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, August 19, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, August 19, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, October 1, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 1, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
